These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 23423859)

  • 21. Myeloid-derived suppressor cells inhibit T cell proliferation in human extranodal NK/T cell lymphoma: a novel prognostic indicator.
    Zhang H; Li ZL; Ye SB; Ouyang LY; Chen YS; He J; Huang HQ; Zeng YX; Zhang XS; Li J
    Cancer Immunol Immunother; 2015 Dec; 64(12):1587-99. PubMed ID: 26497849
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD38 expression predicts poor prognosis and might be a potential therapy target in extranodal NK/T cell lymphoma, nasal type.
    Wang L; Wang H; Li PF; Lu Y; Xia ZJ; Huang HQ; Zhang YJ
    Ann Hematol; 2015 Aug; 94(8):1381-8. PubMed ID: 25865943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined chemoradiation for the management of nasal natural killer (NK)/T-cell lymphoma: elucidating the significance of systemic chemotherapy.
    Guo Y; Lu JJ; Ma X; Wang B; Hong X; Li X; Li J
    Oral Oncol; 2008 Jan; 44(1):23-30. PubMed ID: 17306611
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Prognostic factors of nasal NK/T-cell lymphoma].
    Ma Q; Zhang HL; Liu X; Zhou SY; Qian ZZ; Zhai QL; Fu K; Wang HQ
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Dec; 48(12):1011-6. PubMed ID: 24507001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatments and Outcomes of Patients With Extranodal Natural Killer/T-Cell Lymphoma Diagnosed Between 2000 and 2013: A Cooperative Study in Japan.
    Yamaguchi M; Suzuki R; Oguchi M; Asano N; Amaki J; Akiba T; Maeda T; Itasaka S; Kubota N; Saito Y; Kobayashi Y; Itami J; Ueda K; Miyazaki K; Ii N; Tomita N; Sekiguchi N; Takizawa J; Saito B; Murayama T; Ando T; Wada H; Hyo R; Ejima Y; Hasegawa M; Katayama N
    J Clin Oncol; 2017 Jan; 35(1):32-39. PubMed ID: 28034070
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic impact of absolute lymphocyte count/absolute monocyte count ratio and prognostic score in patients with nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Zhang L; Song HL; Zhang J; Weng HW; Zou LQ
    Tumour Biol; 2017 May; 39(5):1010428317705503. PubMed ID: 28475009
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical features and prognostic model for extranasal NK/T-cell lymphoma.
    Jo JC; Yoon DH; Kim S; Lee BJ; Jang YJ; Park CS; Huh J; Lee SW; Ryu JS; Suh C
    Eur J Haematol; 2012 Aug; 89(2):103-10. PubMed ID: 22553935
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic impact of beta-2 microglobulin in patients with extranodal natural killer/T cell lymphoma.
    Yoo C; Yoon DH; Jo JC; Yoon S; Kim S; Lee BJ; Huh J; Lee SW; Suh C
    Ann Hematol; 2014 Jun; 93(6):995-1000. PubMed ID: 24441948
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating Low Absolute CD4+ T Cell Counts May Predict Poor Prognosis in Extranodal NK/T-Cell Lymphoma Patients Treating with Pegaspargase-Based Chemotherapy.
    Zhang YP; Zhang R; Zhu HY; Wang L; Wu YJ; Liang JH; Shi WY; Liu H; Xu W; Li JY
    Cancer Res Treat; 2019 Jan; 51(1):368-377. PubMed ID: 29764116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The serum CXCL13 level is associated with the Glasgow Prognostic Score in extranodal NK/T-cell lymphoma patients.
    Kim SJ; Ryu KJ; Hong M; Ko YH; Kim WS
    J Hematol Oncol; 2015 May; 8():49. PubMed ID: 25966773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High numbers of CD68+ tumor-associated macrophages correlate with poor prognosis in extranodal NK/T-cell lymphoma, nasal type.
    Wang H; Li P; Wang L; Xia Z; Huang H; Lu Y; Li Z
    Ann Hematol; 2015 Sep; 94(9):1535-44. PubMed ID: 25990795
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for mature natural killer (NK) cell neoplasms: aggressive NK cell leukemia and extranodal NK cell lymphoma, nasal type.
    Suzuki R; Suzumiya J; Yamaguchi M; Nakamura S; Kameoka J; Kojima H; Abe M; Kinoshita T; Yoshino T; Iwatsuki K; Kagami Y; Tsuzuki T; Kurokawa M; Ito K; Kawa K; Oshimi K;
    Ann Oncol; 2010 May; 21(5):1032-40. PubMed ID: 19850638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fasting blood glucose is a novel prognostic indicator for extranodal natural killer/T-cell lymphoma, nasal type.
    Cai Q; Luo X; Liang Y; Rao H; Fang X; Jiang W; Lin T; Lin T; Huang H
    Br J Cancer; 2013 Feb; 108(2):380-6. PubMed ID: 23299534
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma.
    Yhim HY; Kim JS; Mun YC; Moon JH; Chae YS; Park Y; Jo JC; Kim SJ; Yoon DH; Cheong JW; Kwak JY; Lee JJ; Kim WS; Suh C; Yang DH;
    Biol Blood Marrow Transplant; 2015 Sep; 21(9):1597-604. PubMed ID: 25963920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical features and prognosis of nasal type NK/T cell lymphoma].
    Zhang YJ; Hu WH; Liu H; Cheng EC; Ren ZM; Xia YF; Cui NJ
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):50-3. PubMed ID: 16737622
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Therapy and prognosis analysis of 47 patients with extranodal NK/T-cell lymphoma].
    Zhang SS; Wei M; Li HH; Jing Y; Li F; Huang WR; Lu XL; Liu ZX; Zhou Y; Yu L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2011 Feb; 19(1):119-23. PubMed ID: 21362235
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The value of prognostic nutritional index in nasal-type, extranodal natural killer/T-cell lymphoma.
    Li N; Jiang M; Wu WC; Zou LQ
    Ann Hematol; 2022 Jul; 101(7):1545-1556. PubMed ID: 35635579
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nongastric marginal zone B-cell lymphoma: a prognostic model from a retrospective multicenter study.
    Oh SY; Kwon HC; Kim WS; Park YH; Kim K; Kim HJ; Kwon JM; Lee J; Ko YH; Ahn YC; Oh SJ; Lee SI; Bang SM; Kim JH; Park J; Ryoo BY; Lee SS; Kim HY; Park K; Kim HJ
    Cancer Lett; 2007 Dec; 258(1):90-7. PubMed ID: 17936499
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extranodal nasal type NK/T-cell lymphoma: elucidating clinical prognostic factors for risk-based stratification of therapy.
    Lee J; Park YH; Kim WS; Lee SS; Ryoo BY; Yang SH; Park KW; Kang JH; Park JO; Lee SH; Kim K; Jung CW; Park YS; Im YH; Kang WK; Lee MH; Ko YH; Ahn YC; Park K
    Eur J Cancer; 2005 Jul; 41(10):1402-8. PubMed ID: 15963893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.